Veeva Systems (VEEV) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Jan, 2026Executive summary
Q2 FY2025 revenue reached $676.2 million, up 15% year-over-year, with subscription services revenue at $561.3 million and services revenue at $114.9 million.
Net income grew 53% year-over-year to $171 million; non-GAAP operating income was $279.8 million with a margin of 41.4%.
Major product advances included the launch of Vault CRM Service Center, Site Connect, and new clinical platform capabilities, with 14 new Vault CRM customers and 12 Vault Basics customers added.
Strategic customer wins included top 20 biopharma standardizing on Vault RIM Suite and Vault CTMS, and strong adoption in R&D Solutions.
The company maintains a strong liquidity position with $4.9 billion in cash, cash equivalents, and short-term investments as of July 31, 2024.
Financial highlights
Subscription services revenue grew 19% year-over-year to $561.3 million; professional services revenue declined 4% to $114.9 million.
Non-GAAP total gross margin for Q2 FY2025 was 77.2%; subscription services gross margin was 86.5%.
GAAP operating margin was 24.6%; non-GAAP operating margin was 41.4%.
Net cash provided by operating activities for the six months ended July 31, 2024, was $856.4 million.
Diluted EPS was $1.04 (GAAP) and $1.62 (non-GAAP) for the quarter.
Outlook and guidance
Q3 FY2025 revenue guidance is $682–$685 million, with non-GAAP operating income of $273–$275 million and non-GAAP EPS of $1.57–$1.58.
FY2025 revenue guidance is $2,704–$2,710 million, with non-GAAP operating income of ~$1,080 million and non-GAAP EPS of ~$6.22.
FY2025 normalized billings are guided at ~$2,880 million, up ~11% year-over-year, including a $15 million tailwind from customer billing term changes.
Management expects higher costs in subscription services, R&D, and sales and marketing due to increased compensation and investment.
Cash flows from operating activities are expected to be lower in future quarters due to seasonality and tax law changes.
Latest events from Veeva Systems
- FY 2026 revenue and net income rose sharply, with robust outlook and accelerating AI-driven growth.VEEV
Q4 20265 Mar 2026 - All proposals were recommended for approval, with voting results to be filed publicly.VEEV
AGM 20243 Feb 2026 - Growth accelerates as unified platform, AI, and new products expand market share and customer value.VEEV
Baird 2024 Global Consumer, Technology & Services Conference1 Feb 2026 - Integrated platform and data innovation fuel durable growth and leadership in life sciences.VEEV
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Vault CRM and unified platforms drive growth as life sciences invests in innovation.VEEV
Citi's 2024 Global TMT Conference22 Jan 2026 - 2030 revenue goal set at $6B, with organic growth and new market expansion as key drivers.VEEV
Investor Day 202415 Jan 2026 - AI-driven life sciences cloud growth targets $6B revenue and diversified leadership by 2030.VEEV
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026 - Q3 revenue up 13% to $699M, 43.5% margin, strong subscription and AI-driven growth.VEEV
Q3 202511 Jan 2026 - Integrated innovation and disciplined growth drive confidence in $6B revenue targets by 2030.VEEV
Raymond James 2024 TMT & Consumer Conference11 Jan 2026